New Issue: Orbital Catastrophe Ahead? Read Now

Naive Immune Cells with "False Memories" Fight Like Old Pros

Join Our Community of Science Lovers!

T cells are the killers of the immune system, but like all good soldiers, they need experience before they can perform effectively. Indeed, T cells that have fought a particular infection before are much better than their inexperienced counterparts at clearing it from the body. This much scientists have long known. But new research suggests that there is more to the story. Researchers have discovered that some seemingly naive T cells are just as effective against infection as their experienced brethren.

Immunologist Sara Hamilton of the University of Minnesota and her colleagues challenged the immune systems of mice by exposing them to radiation. They then introduced fresh T cells that had been cultured in the lab into their immune system. These T cells somehow recognized that they were few in number and began to proliferate.

The scientists then exposed these new T cells, along with regular na¿ve T cells and experienced T cells to the pathogen: Listeria monocytogenes, which can produce flulike symptoms in humans. The proliferated T cells killed the Listeria just as well as their peers with prior memory of the microbe.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


"The memory cells have this heightened ability to protect us, they have a better capability of dealing with recurrent infection," Hamilton explains. "These [proliferated] cells are able to do that [even] though they've never been primed to see the antigen. On a per cell basis, they were just as good as the real memory cells."

These false-memory T cells raise further questions: to be effective infection fighters, the cells needed to proliferate in the presence of their immune cell counterparts or be genetically modified to fail to produce the TRAIL molecule, a protein linked to programmed cell death. "The part we don't know is how that TRAIL molecule is working," Hamilton says. It may be that other secreted proteins, such as cytokines, are equally important as well.

The finding could, however, provide a new pathway for boosting otherwise damaged immune systems. If radiated mice can create false memories in transplanted T cells that improve their infection-fighting performance, it may be that radiated cancer patients or others whose immune systems are compromised can do the same. The research appeared in yesterday's Nature Immunology.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe